Unsupervised Walking Activity Assessment Reveals COVID-19 Impact on Parkinson's Disease Patients

Mov Disord. 2021 Mar;36(3):531-532. doi: 10.1002/mds.28514. Epub 2021 Jan 27.

Diogo Vila-Viçosa¹, Ana Clemente¹, Filipa Pona-Ferreira², Mariana Leitão², Raquel Bouça-Machado^{2

3}, Linda A Kauppila⁴, Rui M Costa^{5

6}, Ricardo Matias^{5

7

8}, Joaquim J Ferreira^{2

3

9}

¹ Kinetikos, Coimbra, Portugal.
² CNS-Campus Neurológico Sénior, Torres Vedras, Portugal.
³ Instituto de Medicina Molecular João Lobo Antunes, Lisbon, Portugal.
⁴ Department of Neurosciences and Mental Health, Neurology, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.
⁵ Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal.
⁶ Zuckerman Mind Brain Behavior Institute, Columbia University, New York, New York, USA.
⁷ Champalimaud Clinical Centre, Champalimaud Centre for the Unknown, Lisbon, Portugal.
⁸ Human Movement Analysis Lab, Escola Superior Saúde - Instituto Politécnico de Setúbal, Setúbal, Portugal.
⁹ Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.

No abstract available

Keywords: activities of daily living; functional mobility; movement disorders; telemedicine.

Publication types